Delivery Order SPE2DB22D2108-SPE2DB25FU4RB

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,128.81, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S", a pharmaceutical product, with a period of performance through December 10, 2024. The contract is not designated as a set-aside....
This federal contract award, valued at $1,318.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTROGEN-METHYLTESTOS F.S. TAB 100S, a medical product, and has an ultimate completion date of June 28, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation indicated. Amerisourcebergen holds a...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide ESTROGEN-METHYLTESTOS H.S. TAB 100S pharmaceutical product with a potential value of $1,385.28. The delivery order has a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this award. The delivery order is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,690.73, is for the delivery of Estrogen-Methyltestos F.S. Tab 100s, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of October 28, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,335.67 firm fixed-price delivery order (SPE2DB20D3103|SPE2DB24FP1Q2) is for the supply of ESTROGEN-METHYLTESTOS F.S. TAB 100S, a pharmaceutical product, with a completion date of June 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ESTROGEN-METHYLTESTOS F.S. TAB 100S. The contract has a ceiling value of $1,344.18 and is a Firm Fixed Price Delivery Order that expires on September 24, 2024. AmerisourceBergen, through its Corporate Office division, has a significant presence as a supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award is a delivery order valued at $2,468.80 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the purchase of Estrogen-Methyltestos F.S. Tablets in quantities of 100s. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,467.12 contract is for the delivery of Estrogen-Methyltestosterone hydrochloride tablets to support military treatment programs and facilities. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $515,790.04 and an ultimate completion date of May 13, 2024. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a range of pharmaceutical and medical products. The contract has a ceiling value of $431,005.93 and a performance period through May 14, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB25FU4RB
    Delivery Order

This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a pharmaceutical product, with a ceiling value of $1,390.68 and a performance period ending on June 4, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is issued under that larger IDC contract, enabling Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

The contract is not designated as a set-aside and is open to competition. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/2/25, 9:54 AM